| Product Code: ETC9940001 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Cancer Treatment Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Cancer Treatment Market - Industry Life Cycle |
3.4 United Kingdom (UK) Cancer Treatment Market - Porter's Five Forces |
3.5 United Kingdom (UK) Cancer Treatment Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 United Kingdom (UK) Cancer Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United Kingdom (UK) Cancer Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United Kingdom (UK) Cancer Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Cancer Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer cases in the UK |
4.2.2 Technological advancements in cancer treatment |
4.2.3 Growing investments in research and development for cancer therapies |
4.3 Market Restraints |
4.3.1 High cost of cancer treatments |
4.3.2 Limited access to advanced cancer care facilities in certain regions of the UK |
4.3.3 Stringent regulatory requirements for approval of new cancer treatments |
5 United Kingdom (UK) Cancer Treatment Market Trends |
6 United Kingdom (UK) Cancer Treatment Market, By Types |
6.1 United Kingdom (UK) Cancer Treatment Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.4 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Colorectal Cancer with Liver Metastases, 2021- 2031F |
6.1.5 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Lung Carcinoma, 2021- 2031F |
6.1.6 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.7 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.1.8 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Head-And-Neck Cancer, 2021- 2031F |
6.1.9 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Glioblastoma, 2021- 2031F |
6.1.10 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Glioblastoma, 2021- 2031F |
6.2 United Kingdom (UK) Cancer Treatment Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Targeted Therapies, 2021- 2031F |
6.2.4 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Radiotherapy, 2021- 2031F |
6.2.5 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3 United Kingdom (UK) Cancer Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.3 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4 United Kingdom (UK) Cancer Treatment Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United Kingdom (UK) Cancer Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 United Kingdom (UK) Cancer Treatment Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Cancer Treatment Market Export to Major Countries |
7.2 United Kingdom (UK) Cancer Treatment Market Imports from Major Countries |
8 United Kingdom (UK) Cancer Treatment Market Key Performance Indicators |
8.1 Average survival rates of cancer patients in the UK |
8.2 Adoption rate of innovative cancer treatment technologies |
8.3 Number of clinical trials for cancer treatments conducted in the UK |
9 United Kingdom (UK) Cancer Treatment Market - Opportunity Assessment |
9.1 United Kingdom (UK) Cancer Treatment Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 United Kingdom (UK) Cancer Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United Kingdom (UK) Cancer Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United Kingdom (UK) Cancer Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Cancer Treatment Market - Competitive Landscape |
10.1 United Kingdom (UK) Cancer Treatment Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Cancer Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here